NOVAVAX INC (NVAX) Operating cash flow 2016–2025
NOVAVAX INC (NVAX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$244.6MFY2025 · since FY2016: -$258.8M → -$244.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$244.6M | -180.3% |
| FY2024 | -$87.3M | +87.8% |
| FY2023 | -$714.0M | -71.7% |
| FY2022 | -$415.9M | -228.8% |
| FY2021 | $322.9M | +859.1% |
| FY2020 | -$42.5M | +68.9% |
| FY2019 | -$136.6M | +26.1% |
| FY2018 | -$184.8M | -27.9% |
| FY2017 | -$144.5M | +44.2% |
| FY2016 | -$258.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVAX financial trends
NVAX RevenueNVAX Net incomeNVAX Net marginNVAX Gross profitNVAX Gross marginNVAX Operating incomeNVAX Operating marginNVAX Free cash flowNVAX Capital expendituresNVAX Return on equityNVAX Stock buybacksNVAX Dividends paidNVAX Total assetsNVAX Total liabilitiesNVAX Shareholders’ equityNVAX overview →